Ibuprofen

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with various conditions, including headache, muscular aches, minor pain of arthritis, toothache, backache, the common cold, and menstrual cramps. Additionally, it is indicated for the temporary reduction of fever.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children 12 years and older are advised to take 1 caplet every 4 to 6 hours as needed while symptoms persist. In cases where pain or fever does not adequately respond to 1 caplet, a dosage of 2 caplets may be administered. It is imperative that the total daily dosage does not exceed 6 caplets within a 24-hour period, unless otherwise directed by a healthcare professional.

For children under 12 years of age, it is recommended to consult a doctor for appropriate dosing guidance.

Contraindications

Use is contraindicated in patients with a history of allergic reactions to ibuprofen or any other pain reliever or fever reducer. Additionally, administration is contraindicated immediately before or after heart surgery due to potential complications associated with surgical recovery.

Warnings and Precautions

Ibuprofen has the potential to induce severe allergic reactions, particularly in individuals with a known allergy to aspirin. Symptoms indicative of such reactions may include hives, facial swelling, asthma (characterized by wheezing), shock, skin reddening, rash, and blisters. In the event of an allergic reaction, it is imperative to discontinue use immediately and seek medical assistance without delay.

Healthcare professionals should advise patients to stop using ibuprofen and consult a physician if they experience any signs of stomach bleeding. These signs may manifest as feeling faint, vomiting blood, passing bloody or black stools, or experiencing stomach pain that does not improve. Additionally, patients should be instructed to seek medical attention if they exhibit symptoms suggestive of heart problems or stroke, which may include chest pain, difficulty breathing, unilateral weakness, slurred speech, or leg swelling.

Patients are also cautioned to discontinue use and consult a healthcare provider if pain persists or worsens beyond a duration of 10 days, if fever intensifies or lasts longer than 3 days, if there is noticeable redness or swelling in the affected area, or if any new symptoms arise. Regular monitoring of these parameters is essential to ensure patient safety during ibuprofen therapy.

Side Effects

Patients may experience a range of adverse reactions while using ibuprofen, which can vary in seriousness and frequency.

Severe allergic reactions have been reported, particularly in individuals with a known allergy to aspirin. Symptoms of such reactions may include hives, facial swelling, asthma (wheezing), shock, skin reddening, rash, and blisters.

In clinical settings, patients are advised to discontinue use and consult a healthcare professional if they exhibit signs of stomach bleeding, which may manifest as feeling faint, vomiting blood, having bloody or black stools, or experiencing persistent stomach pain. Additionally, symptoms indicative of heart problems or stroke, such as chest pain, difficulty breathing, unilateral weakness, slurred speech, or leg swelling, warrant immediate medical attention.

Other common adverse reactions include worsening pain that persists beyond 10 days, a fever that intensifies or lasts more than 3 days, redness or swelling in the painful area, or the emergence of any new symptoms.

Patients with a history of serious side effects from pain relievers or fever reducers, those with pre-existing stomach issues (e.g., heartburn), and individuals with conditions such as high blood pressure, heart disease, liver cirrhosis, kidney disease, or asthma should consult a healthcare provider before using ibuprofen. Furthermore, patients taking diuretics or aspirin for cardiovascular protection should seek medical advice, as ibuprofen may diminish the efficacy of aspirin in these contexts.

It is essential for patients to remain vigilant regarding these potential adverse reactions and to communicate any concerns with their healthcare provider.

Drug Interactions

Ibuprofen has been observed to potentially decrease the antiplatelet effect of aspirin when administered concurrently. This interaction may lead to an increased risk of cardiovascular events. It is advisable for healthcare professionals to monitor patients closely for any signs of cardiovascular complications when these medications are used together.

No additional drug interactions or laboratory test interactions have been reported.

Packaging & NDC

Below are the non-prescription pack sizes of Ibuprofen. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Children under 12 years of age should consult a healthcare professional before use. For adolescents and adults aged 12 years and older, the recommended dosage is 1 caplet every 4 to 6 hours as needed for symptom relief. If pain or fever does not adequately respond to 1 caplet, 2 caplets may be administered. The maximum allowable dosage is 6 caplets within a 24-hour period, unless otherwise directed by a healthcare provider.

Geriatric Use

Elderly patients, particularly those aged 60 and older, may have an increased risk of severe stomach bleeding. It is essential for healthcare providers to exercise caution when prescribing medications that may exacerbate this risk in this population. Close monitoring for gastrointestinal symptoms is recommended, and dosage adjustments should be considered based on the individual patient's health status and concurrent medications. Careful assessment of the benefits and risks is crucial when treating geriatric patients to ensure their safety and well-being.

Pregnancy

Pregnant patients should consult a healthcare professional before using this medication, particularly if they are in the later stages of pregnancy or breastfeeding. It is especially important to avoid the use of ibuprofen during the last trimester unless specifically directed by a physician, as it may pose risks to the developing fetus and lead to complications during delivery. Healthcare providers should weigh the potential benefits against the risks when considering the use of this medication in pregnant patients.

Lactation

Lactating mothers are advised to consult a healthcare professional before using this medication. It is particularly important to avoid the use of ibuprofen during the last three months of pregnancy unless specifically directed by a physician, as it may pose risks to the unborn child or lead to complications during delivery. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, caution is recommended when considering its use in lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring of these patients.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

There is currently no specific information available regarding overdosage for this medication. In the absence of documented overdosage data, healthcare professionals are advised to exercise caution and monitor patients closely for any unusual symptoms or adverse effects that may arise following administration.

In the event of suspected overdosage, it is recommended that healthcare providers initiate supportive care and symptomatic treatment as necessary. Monitoring of vital signs and laboratory parameters may be warranted to assess the patient's condition and guide further management.

Healthcare professionals should remain vigilant for potential symptoms that could indicate an overdosage scenario, although specific symptoms have not been detailed. If any concerning signs or symptoms develop, appropriate medical intervention should be sought immediately.

For further guidance, healthcare providers are encouraged to consult local poison control centers or relevant medical authorities to obtain the most current recommendations for managing suspected overdosage cases.

Nonclinical Toxicology

It is especially important not to use ibuprofen during the last three months of pregnancy unless definitely directed to do so by a doctor, as it may cause problems in the unborn child or complications during delivery. No specific non-teratogenic effects have been identified in the available data. Additionally, there are no details regarding nonclinical toxicology or animal pharmacology and toxicology provided in the current information.

Postmarketing Experience

Postmarketing experience has identified several adverse reactions associated with the use of ibuprofen. These include gastrointestinal bleeding, renal impairment, liver enzyme elevations, and hypersensitivity reactions, which may manifest as anaphylaxis. Additionally, skin reactions such as Stevens-Johnson syndrome and toxic epidermal necrolysis have been reported. Cardiovascular events, including heart attack and stroke, have also been noted.

Further safety information from postmarketing data indicates occurrences of elevated blood pressure, fluid retention, and exacerbation of heart failure.

Monitoring for these adverse reactions is advised, particularly in patients with pre-existing conditions or those concurrently using other medications that may heighten the risk of these events.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center at 1-800-222-1222 in the event of an overdose. Patients should be informed to take the medication with food or milk if they experience stomach upset.

Patients must be instructed to discontinue use and consult a doctor if they notice any signs of stomach bleeding, which include feeling faint, vomiting blood, having bloody or black stools, or experiencing stomach pain that does not improve. Additionally, they should stop use and seek medical advice if they experience symptoms indicative of heart problems or stroke, such as chest pain, difficulty breathing, weakness on one side of the body, slurred speech, or swelling in the legs.

Patients should be counseled to monitor their pain; if it worsens or persists for more than 10 days, or if a fever worsens or lasts more than 3 days, they should contact their healthcare provider. They should also report any redness or swelling in the painful area or the appearance of any new symptoms.

It is important for healthcare providers to remind patients to consult a doctor before use if they have experienced problems or serious side effects from pain relievers or fever reducers in the past. Patients with a history of stomach issues, such as heartburn, or those for whom the stomach bleeding warning applies should also seek medical advice prior to use.

Furthermore, patients with high blood pressure, heart disease, liver cirrhosis, kidney disease, asthma, or a history of stroke should be advised to consult a doctor before using this medication. Those taking diuretics or aspirin for heart attack or stroke should also be encouraged to discuss their use with a healthcare provider, as ibuprofen may diminish the benefits of aspirin. Lastly, patients under a doctor's care for any serious condition or those taking other medications should be advised to consult a doctor or pharmacist before use.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at a temperature range of 20-25°C (68-77°F), in accordance with USP Controlled Room Temperature guidelines. Proper storage conditions must be maintained to ensure the integrity and efficacy of the product.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Ibuprofen, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)